<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<meta name="format-detection" content="telephone=no">
<title>FORTEO 雙重作用機轉 Remodeling & Modeling | NOV,2022</title>
<style>
html{
    background:#F8F6F5}
body{
    width: 100%;
	margin:0;
	padding:0;
    font-family:'Microsoft JhengHei','PingFangTC-Regular', 'Arial', 'Helvetica', sans-serif}
tr,
td{ margin:0;
	padding:0;}
img{
    display:block;
    margin: 0;
    padding: 0;
	border:0}
</style>
</head>


<body>
    <table width="640" cellspacing="0" cellpadding="0" style="margin: 0 auto; background-color: #eee; border-collapse: collapse;">
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_01.png" width="640" height="252" style="display:block;outline:0;border:0" alt="FORTEO 雙重作用機轉 Remodeling & Modeling">
            </td>
        </tr>
        <tr style="width:100%; height: 47px;background-color: #ffffff;">
            <td style="width:100%; height: 47px; background-image:url(https://www.iprc.com.tw/edm/forteo/images/edm-13_02.png); background-repeat: no-repeat; background-size: cover;">
                <p style="display:block; font-family:Helvetica, 'Microsoft JhengHei','PingFangTC-Regular', 'Arial', sans-serif; font-weight: bold; font-size: 18px; color:#0f3767; line-height: 0; padding:0 0 0 40px; vertical-align: middle;">Dear Doctor. {{accLname}} {{accFname}} {{accTitle}}:</p>
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_03.png" width="640" height="144" style="display:block;outline:0;border:0" alt="There has been renewed interest of late in the role of modeling-based formation (MBF) during osteoporosis therapy. Here we describe early effects of an established anabolic (teriparatide) on remodeling-based formation (RBF), modeling-based formation (MBF), and overflow MBF (oMBF) in human transiliac bone biopsies.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_04.png" width="640" height="94" style="display:block;outline:0;border:0" alt="Study Design :Postmenopausal women with osteoporosis received subcutaneous teriparatide (n=33, 20mgld) or denosumab (n=36, 60mg once/6 months), open-label for 6 months at 7 US and Canadian sites. Subjects received double fluorochrome labeling at baseline and before biopsy at 3 months.">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_05.png" width="640" height="104" style="display:block;outline:0;border:0" alt="Three different types of bone-forming units for teriparatide MBF, RBF, OMBF">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_06.png" width="640" height="68" style="display:block;outline:0;border:0" alt="MBF, RBF, OMBF list">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_07.png" width="640" height="277" style="display:block;outline:0;border:0" alt="MBF, RBF, OMBF list">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_08.png" width="640" height="61" style="display:block;outline:0;border:0" alt="fluorochrome labels">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_09.png" width="640" height="135" style="display:block;outline:0;border:0" alt="All types of formation significantly increased from baseline in the cancellous and endocortical envelopes (differences p<0.001) with Teriparatide">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_10.png" width="640" height="304" style="display:block;outline:0;border:0" alt="chart">
            </td>
        </tr>
        <tr>
            <td><a href="https://asbmr.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.3309" target="_blank" title="Register now" rel="noreferrer noopener">
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_11.png" width="640" height="109" style="display:block;outline:0;border:0" alt="Learn more about reducing fracture risk? Find more here!" >
                </a>
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_12.png" width="640" height="131" style="display:block;outline:0;border:0" alt="QUALITY OF BONE QUALITY OF LIFE">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_13.png" width="640" height="167" style="display:block;outline:0;border:0" alt="#">
            </td>
        </tr>
        <tr>
            <td>
                <img src="https://www.iprc.com.tw/edm/forteo/images/edm-13_14.png" width="640" height="92" style="display:block;outline:0;border:0" alt="骨種® 注射液 Forteo Iteriparatidel For Injection">
            </td>
        </tr>
        <tr>
            <td style="padding: 15px 0 15px 0; background:#ffffff">
                <div style="font-family:sans-serif">
                    <div class="txtTinyMce-wrapper" style="font-size:12px;mso-line-height-alt:16.8px;color:#737372;line-height:18px;font-family:Arial,Helvetica Neue,Helvetica,sans-serif">
                    <p style="margin:0;text-align:center">© 2022 Zuellig Pharma Holdings Pte. Ltd. All rights reserved.</p>
                    <p style="margin:0;text-align:center">
                        <a href="https://www.zuelligpharma.com/legal-disclaimer" target="_blank" rel="noopener" style="color: #313e5b;">Legal Disclaimer&nbsp;</a>&nbsp;|
                        <a href="https://www.zuelligpharma.com/privacy-policy" target="_blank" rel="noopener" style="color: #313e5b;">&nbsp;Privacy Policy</a>
                        |&nbsp;
                        <a href="{{unsubscribe_product_link[,ZLG_CONTENT_TYPES]}}" target="_blank" style="text-decoration: underline; color: #313e5b;" rel="noopener">&nbsp;Unsubscribe</a>&nbsp;
                    </p>
                    </div>
                </div>
            </td>
        </tr>
    </table>
</body>
</html>